SCHEMBL19904542

SCHEMBL19904542

O=C(NC(Cc1cc(F)c2c(c1)OCCO2)CN1CCCC1)C1CCN(c2ccc(F)cc2)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UGCG Q16739 1/20 0.40
NOTUM Q6P988 2/20 0.39
SSTR3 P32745 1/20 0.38
KDM4E B2RXH2 2/20 0.37
TSHR P16473 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
HSD17B10 Q99714 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CHRM4 P08173 1/20 0.35
LMNA P02545 2/20 0.35
PKM P14618 1/20 0.35
DEGS1 O15121 1/20 0.35
KMT2A Q03164 3/20 0.34
HTR1A P08908 1/20 0.34
HTR4 Q13639 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19904389 1.00 UGCG (0.40) UGCGNOTUMSSTR3KDM4ETSHR
SCHEMBL19904427 0.94 KMT2A (0.38) UGCGNOTUMSSTR3KDM4ETSHR
SCHEMBL19904498 0.93 KDM4E (0.37) UGCGNOTUMSSTR3KDM4ETSHR
SCHEMBL19904551 0.93 HTR1A (0.38) UGCGNOTUMSSTR3KDM4ETSHR
SCHEMBL19904368 0.93 HTR1A (0.38) UGCGNOTUMSSTR3KDM4ETSHR
SCHEMBL19904488 0.92 KMT2A (0.38) UGCGNOTUMSSTR3KDM4ETSHR
SCHEMBL19904324 0.92 KDM4E (0.37) UGCGNOTUMSSTR3KDM4ELMNA
SCHEMBL19904535 0.92 KDM4E (0.37) UGCGNOTUMSSTR3KDM4ELMNA
SCHEMBL19904506 0.92 TRPV1 (0.39) UGCGNOTUMSSTR3KDM4ETSHR
SCHEMBL19904550 0.90 UGCG (0.35) UGCGNOTUMSSTR3KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed